The microbiome in bronchiectasis

James D. Chalmers (Dundee (Angus), United Kingdom)

Source: ERS Lung Science Conference 2019
Number: 6
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
James D. Chalmers (Dundee (Angus), United Kingdom). The microbiome in bronchiectasis. ERS Lung Science Conference 2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
The fungal microbiome and its role in bronchiectasis
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019

The microbiome in IPF
Source: International Congress 2014 – ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)"
Year: 2014

Immunometabolic markers and the sputum microbiome in bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021

The pulmonary microbiome in non-cystic fibrosis bronchiectasis.
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017

Gut microbiome in COPD
Source: International Congress 2016 – Microbiome in health and in disease
Year: 2016

The microbiome in interstitial lung disease
Source: Lung Science Conference 2015
Year: 2015

The study of airway microbiome and mycobiome of COPD and AECOPD patients
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018

The effect of exacerbations on the airway microbiota in children with non-CF bronchiectasis
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019

Implications of the microbiome and mycobiome in cystic fibrosis
Source: International Congress 2015 – Microbial impacts at different human ages
Year: 2015

The difference of airway microbiota between nontuberculous mycobacteria lung disease and bronchiectasis
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020

The lower airways microbiome in patients with IPF and COPD
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019

The pulmonary microbiome in sarcoidosis is similar to other parenchymal lung diseases
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018

The airway microbiota and exacerbations of COPD
Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020
Year: 2020

A molecular comparison of microbial communities in bronchiectasis and cystic fibrosis
Source: Eur Respir J 2013; 41: 991-993
Year: 2013

Bacterial dysbiosis in pediatric lung diseases such as asthma and CF
Source: Virtual Congress 2020 – Bugs secret's: the way the microbiome changes our future
Year: 2020

The pulmonary bacterial and fungal microbiota in sarcoidosis patients.
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021

The cystic fibrosis lower airways microbial metagenome
Source: ERJ Open Res 2016: 00096-2015
Year: 2016

Lung microbiome dysbiosis is associated with mortality in COPD
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019

Ivacaftor/lumacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020